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Available online 20 February 2017Neurofibromatosis Type 1 (NF1) is a monogenetic autosomal-dominant disorder with a broad spectrum of clin-
ical symptoms and is commonly associatedwith cognitive deficits. Patients with NF1 frequently exhibit cognitive
impairments like attention problems, workingmemory deficits and dysfunctional inhibitory control. The latter is
also relevant for the resolution of cognitive conflicts. However, it is unclear how conflictmonitoring processes are
modulated in NF1. To examine this question inmore detail, we used a systemneurophysiological approach com-
bining high-density ERP recordings with source localisation analyses in juvenile patients with NF1 and controls
during a flanker task. Behaviourally, patients with NF1 perform significantly slower than controls. Specifically on
trials with incompatible flanker-target pairings, however, the patients with NF1 made significantly fewer errors
than healthy controls. Yet, importantly, this overall successful conflict resolution was reached via two different
routes in the two groups. The healthy controls seem to arrive at a successful conflict monitoring performance
through a developing conflict recognition via the N2 accompanied by a selectively enhanced N450 activation
in the case of perceived flanker-target conflicts. The presumed dopamine deficiency in the patients with NF1
seems to result in a reduced ability to process conflicts via the N2. However, NF1 patients show an increased
N450 irrespective of cognitive conflict. Activation differences in the orbitofrontal cortex (BA11) and anterior cin-
gulate cortex (BA24) underlie these modulations. Taken together, juvenile patients with NF1 and juvenile
healthy controls seem to accomplish conflict monitoring via two different cognitive neurophysiological
pathways.gy, De
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Neurofibromatosis Type 1 (NF1) is an autosomal dominantmonoge-
netic genetic disorder (MIM #162200) occurring in about 1 out of 3000
children (Lammert et al., 2005) that is caused bymutations in the tumor
suppressor gene neurofibromin 1 (17q11.2, MIM*613113). Aside from
the chronic and often progressive medical and neurological symptoms
(Kayl and Moore, 2000) and an increased susceptibility to the develop-
ment of benign and malignant tumors, cognitive deficits, often resem-
bling those characteristic for patients with Attention Deficit/
Hyperactivity Disorder (ADHD), occur in 30–70% of all NF1 cases (Kayl
and Moore, 2000; Mautner et al., 2015; North et al., 1997; Pride et al.,
2012; van der Voet et al., 2016). Generally, these deficits may occur in
the formof intellectual impairments, learning disabilities and emotional
as well as psychosocial problems (Kayl and Moore, 2000). The precisepartment of Child and
ermany, Schubertstrasse
Bluschke).
s an open access article undercognitive profiles are very heterogeneous and negatively impact quality
of life, academic achievement and social functioning (Huijbregts and de
Sonneville, 2011). Concerning the underlying pathomechanisms, NF1
has been suggested to be associated with deficits in dopaminergic sig-
nalling (Anastasaki et al., 2015; Brown et al., 2010, 2011;
Diggs-Andrews et al., 2013; Diggs-Andrews and Gutmann, 2013; van
der Voet et al., 2016; Wozniak et al., 2013).
Previous research has shown attentional problems (Pride et al.,
2012) and deficits in working memory (Plasschaert et al., 2016) as
well as inhibition (Diggs-Andrews and Gutmann, 2013; Huijbregts et
al., 2010; Koini et al., 2016; Plasschaert et al., 2016; Ribeiro et al.,
2015; Rowbotham et al., 2009). Crucially, inhibitory control has been
shown to significantly influence the resolution of response conflicts
(Klein et al., 2014; Ocklenburg et al., 2011; Verleger et al., 2009). This
has received support by several human (Tandonnet et al., 2011; Taylor
et al., 2007) andmonkey studies (Cisek and Kalaska, 2005). Since inhib-
itory control processes have been shown to be altered in NF1 (Ribeiro et
al., 2015), it is possible that related processes of conflict monitoring are
also dysfunctional in NF1. To examine to what extent conflict monitor-
ing processes are modulated in juvenile patients with NF1 compared tothe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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the flanker task. To examine the neurophysiological underpinnings,
we combined high-density EEG recordings with source localisation
methods to delineate the neurophysiological alterations associated
with changes on the behavioural level. The advantage of electrophysio-
logical (EEG) techniques and event-related potentials (ERPs) in particu-
lar is that different cognitive-neurophysiological subprocesses involved
in information processing (and response inhibition) can be isolated on
the basis of their temporal occurrence.
Conflict monitoring per se is crucially reflected by two main event-
related potentials. On the one hand, the fronto-central N2 has been as-
sociated with the detection of conflicts on the stimulus- and on the re-
sponse-level. Also, it is related to the adjustment of cognitive control
to the perceived conflict, which mainly is associated with activation of
the anterior cingulate cortex (ACC) (Falkenstein et al., 1999, 2002;
Folstein and Van Petten, 2008; Larson et al., 2014; van Veen and
Carter, 2002). Neurobiologically, the N2 component has been strongly
associated with dopaminergic transmission (Beste et al., 2016; Seer et
al., 2016; Zhang et al., 2016). On the other hand, the N450 has been
shown to be specifically sensitive to stimulus (and less so to response)
conflicts. Similar to theN2, theN450 also reflects conflict-related activa-
tion of the ACC (Szűcs and Soltész, 2012). In contrast to the N2, the neu-
robiological underpinnings of theN450 are still rather unclear, although
some dopaminergic involvement has been suggested (Larson et al.,
2015; Li et al., 2013). Overall, the N2 and the N450 are important con-
flict-related components to be examined in patients with NF1, as specif-
ically the functional connectivity of the ACC has been shown to be
deficient in this patient group and this deficit has been explicitly linked
to functional outcomes (Loitfelder et al., 2015).
Aside from conflict processing per se, basic sensory perception and
especially perceptual categorisation of the conflict stimuli are important
contributors to successful conflict processing (Herrmann and Knight,
2001). Also, basic attentional selection processes are crucial in this con-
text. The occipito-parietal P1 and N1 components following the flanker
as well as the target stimuli are well-established neurophysiological
correlates of these early sensory and attentional processes (Herrmann
and Knight, 2001) and thus also need to be examinedwithin the current
study. In addition, response selection processes (as represented by the
central P3) will be examined as well, as they could be affected by the
monitoring and resolution of conflicts (Beste et al., 2011; Mückschel et
al., 2016; Stock et al., 2016).
2. Materials and methods
2.1. Samples
All subjects and their parents or legal guardians provided informed
written consent according to the Declaration of Helsinki and the study
was approved by the local ethics committee of the Medical Faculty of
the TUDresden. 14 patientswithNF1were included in the study (10 fe-
male, 2 brothers, age 13.4 ± 2.5 years). The NF1 diagnoses were based
on the clinical criteria by theNational Institutes of Health (NIH) Consen-
sus Development Conference on Neurofibromatosis (NIH, 1988). 22
children were included in the control group (10 female, 12.7 ±
2.5 years). Noneof themwere takingmedication andnonehad a psychi-
atric diagnosis as confirmed by clinical interview. Age (t(34)=−0.74;
p = 0.47) and sex (χ2 = 2.3; p = 0.13) did not differ between the
groups.
2.2. Task
We used a modified Flanker task to examine response inhibition
processes in the two groups (Bluschke et al., 2016; Chmielewski et al.,
2014). Participants were required to press one of two buttons in re-
sponse to a central target stimulus. If this central arrow pointed to the
right/left, participants were required to also press the button on theright/left. 200 ms before target presentation, two distractor stimuli
(flanker arrows) were presented above and below the location at
which the target arrow would then appear. These flanker arrows
could either point into the same (compatible condition, 67% of trials)
or into the opposite direction (incompatible condition, 33% of trials) as
the subsequent target stimulus. Participants were instructed to ignore
the flanker arrows and to respond according to the direction of the tar-
get arrow as fast as possible. Additional time pressure was created
through an auditory warning stimulus (1000 Hz, 60 db sound pressure
level) presented 1200ms after the response if it had not occurredwithin
450 ms after target presentation. Targets were presented for 300 ms,
with the flankers being switched off simultaneously. The intertrial-in-
terval was pseudo-randomised between 1400 and 1800 ms. The exper-
iment was comprised of four blocks of 120 trials. To examine the effects
of the predictability of trial order on performance, trials in two out of the
four blocks (predictable blocks)were presented in a repetitive order (30
compatible, 20 alternating compatible-incompatible, 20 incompatible,
20 alternating incompatible-compatible, 30 compatible). In the other
two (unpredictable) blocks, trials were presented in a pseudo-
randomised order. In order to avoid occurrences of certain trial se-
quences (i.e. a succession of three equal trials and/or five trials with
the same direction of the target arrow), a sequence of 16 compatible
and 8 incompatible trials was compiled and repeatedly tested inMatlab
until recurrent sequences could be excluded, thus making trial order
unpredictable. Such sequences of 24 trials were used five times within
each of the two unpredictable blocks.
2.3. EEG recording and analyses
We recorded the EEG from 60 Ag/AgCl electrodes at a sampling rate
of 500 Hzwith impedances being kept below 5 kΩ (reference electrode
at Fpz, ground electrode at θ=58,ф=78). Off-line data pre-processing
included a down-sampling of the data to 256 Hz, the application of a
band-pass filter (0.5–20Hz, slope of 48 db/oct) and the removal of tech-
nical as well as periodic artifacts (pulse artifacts, horizontal and vertical
eyemovements). A rawdata inspection as well as an independent com-
ponent analysis was applied to detect and remove/correct such artifacts.
Subsequently, the EEGwas segmented to the onset of the target stimuli.
Only trials with correct responses were included in further analyses.
Each trial was segmented to the period from 2000 ms before to
2000 ms after target onset. An automated artifact rejection procedure
was applied to exclude any remaining trials containing artifacts (rejec-
tion criteria: amplitude criterion (maximal amplitude: 200 μV, minimal
amplitude:−200 μV), maximal value difference (200 μV in a 200ms in-
terval) and low activity (below 0.5 μV in a 100 ms period)). A current
source density (CSD) transformation was used to allow a reference-
free evaluation of the EEG datawhich helps tofind the electrodes show-
ing the strongest effects (Nunez and Pilgreen, 1991). Before averaging
the segments for each condition (compatible and incompatible trials
in the predictable and unpredictable blocks), a baseline correction was
applied from−200ms to 0ms. Based on scalp topography, event-relat-
ed potentials (ERPs)were quantified in the following timewindows and
over the following electrodes: The N2 component was measured over
FCz at 250–290ms (both groups). The N450 component was quantified
over electrodes Fz and FCz in the timewindow of 450–500ms after tar-
get onset. The P1Flanker wasmeasured over electrodes P7, P8, P9 and P10
in both groups during the time window of−100 to−80ms before tar-
get onset. The N1 Flanker was quantified over the same electrodes in the
time window of−30 to−10ms (controls)/−10–10 ms (NF1). For the
P1Target, amplitudes in both groups were measured over the same four
electrodes 115–135 ms after the target. N1Target was quantified at the
same locations at 220–260 ms for the control group and at 200–
220 ms for the patients with NF1. The P3 was quantified at Pz. Based
on the different temporal course apparent in the control group, time
windows were differentially quantified for the compatible (285–
325 ms) and the incompatible (340–380 ms) trials. No such distinction
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electrodes and time windows was validated using a statistical proce-
dure described in Mückschel et al. (2014).
Source localisationwas conducted using sLORETA (standardized low
resolution brain electromagnetic tomography; (Pascual-Marqui,
2002)), providing a single solution to the inverse problem
(Marco-Pallarés et al., 2005; Pascual-Marqui, 2002; Sekihara et al.,
2005). For sLORETA, the intracerebral volume is partitioned into 6239
voxels at 5mm spatial resolution. Then, the standardized current densi-
ty at each voxel is calculated in a realistic head model (Fuchs et al.,
2002) based on the MNI152 template (Mazziotta et al., 2001). It has
been mathematically proven that sLORETA provides reliable results
without a localisation bias (Sekihara et al., 2005). Moreover, there is ev-
idence from EEG/fMRI and neuronavigated EEG/TMS studies
underlining the validity of the sources estimated using sLORETA
(Dippel and Beste, 2015; Sekihara et al., 2005). In this study, the
voxel-based sLORETA images were compared across groups (NF1 vs.
controls) using the sLORETA-built-in voxel-wise randomization tests
with 2000 permutations, based on statistical nonparametric mapping
(SnPM). Voxels with significant differences (p b 0.01, corrected formul-
tiple comparisons) between contrasted conditions were located in the
MNI-brain www.unizh.ch/keyinst/NewLORETA/sLORETA/sLORETA.
htm.2.4. Statistics
Data was analysed using repeated-measures/univariate ANOVAs
and t-tests. Group (controls vs. patients with NF1) was used as the be-
tween-subjects factor. Compatibility (compatible vs. incompatible)
(not applicable to P1Flanker and N1Flanker) as well as Predictability (pre-
dictable vs. unpredictable) were used as the within-subject factors
when analysing both behavioural and neurophysiological data. If neces-
sary in the neurophysiological analysis, Electrode was used as an addi-
tional within-subjects factor, but is only reported when a relevant
interaction with Group is observed. Greenhouse-Geisser correction
was applied for all ANOVAs. Post-hoc tests were Bonferroni-corrected
when necessary. All variables included in the analysis were normallyFig. 1. Event-related potentials (ERPs) (current source density) and topographic maps showing
both groups. The timewindows represented in the scalp topographies are stated in themethod
denotes the occurrence of the target stimulus. Negative values are plotted downwards. Inlays d
trials compared between the two groups. Colours denote t-values corrected using randomizatidistributed, as indicated by Kolmogorov-Smirnov tests (all z b 1.05;
p N 0.2).
3. Results
3.1. Behavioural data
3.1.1. Reaction times (RTs)
Concerning the RTs, we found a significantmain effect of Compatibil-
ity (F(1,32) = 206.4; p b 0.001; ηp2 = 0.87). Reaction times were gener-
ally faster in compatible (345 ± 12 ms) than in incompatible trials
(432 ± 13 ms). In addition, we found a significant main effect of
Group (F(1,32) = 13.6; p = 0.001; ηp2 = 0.30), with healthy controls
generally reacting faster (345 ± 15 ms) than patients with NF1
(432 ± 19 ms). The interaction of Compatibility*Group was not signifi-
cant (F(1,32) = 0.2; p = 0.66; ηp2 = 0.006).
3.1.2. Accuracy
Concerning error rates, we also found significant main effects of
Compatibility (F(1,32) = 103.7; p b 0.001; ηp2 = 0.76) and Group
(F(1,32) = 10.0; p = 0.003; ηp2 = 0.24). Overall, incompatible trials
(37.6 ± 2.3%) resulted in more erroneous responses than compatible
trials (10.9 ± 1.9%). Healthy controls committed more errors (29.5 ±
2.0%) than patientswithNF1 (19.1±2.6%).Most importantly, the inter-
action of Compatibility*Group (F(1,32) = 6.1; p= 0.02; ηp2 = 0.16) was
significant. Analysing this further,we found that the two groups differed
in their error rates on incompatible trials (F(1,32) = 14.0; p = 0.001;
ηp2 = 0.31) (controls: 46.1 ± 2.8%; NF1: 29.2 ± 3.5%), but not on com-
patible trials (F(1,32) = 1.02; p = 0.32; ηp2 = 0.03) (controls: 12.9 ±
2.4%; NF1: 8.9 ± 3.1%). The main effect of Compatibility was significant
both within the healthy controls (F(1,20) = 86.3; p b 0.001; ηp2 =
0.81) and within the patients with NF1 (F(1,12) = 37.3; p b 0.001;
ηp2 = 0.76).
3.2. Neurophysiological data
3.2.1. Conflict detection processes (N2 and N450)
The N2 and N450 components are shown in Fig. 1.the (A) N2 and (B) N450 component during compatible and incompatible flanker trials for
s section. Positive values are given in red, negative values are given in blue. Time point zero
isplay sLORETA analyses. Plots show the difference between compatible and incompatible
on tests.
Fig. 2. Event-related potentials (ERPs) (current source density) and topographic maps
showing the flanker P1, flanker N1, target P1 and target N1 components during
compatible and incompatible flanker trials for both groups. The time windows
represented in the scalp topographies are stated in the methods section. Positive values
are given in red, negative values are given in blue. Time point zero denotes the
occurrence of the target stimulus. Negative values are plotted downwards.
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Compatibility*Group (F(1,34) = 8.2; p = 0.007; ηp2 = 0.19). Further
analyses revealed a significant main effect of Compatibility within the
group of patients with NF1 (F(1, 13) = 5.8; p = 0.03; ηp2 = 0.31). Am-
plitudes were generally more negative in compatible (−38.9 ±
8.4 μV/m2) compared to incompatible trials (−27.7 ± 7.6 μV/m2). The
distinction between compatible (−35.5±4.6 μV/m2) and incompatible
trials (−42.5 ± 6.3 μV/m2) was not significant in the control group
(F(1,21) = 2.9; p = 0.11; ηp2 = 0.12). None of the other main effects
or interactions were significant (all F b 3.7; all p N 0.07; all ηp2 b 0.09).
The sLORETA analysis showed that the differences in N2 amplitudes be-
tween the compatibility conditions and the two groups were due to ac-
tivation differences in the ACC (BA24) and the orbitofrontal cortex
(BA11).
Examining the N450 component, we found a significant interaction
of Compatibility*Group (F(1,34) = 5.1; p = 0.03; ηp2 = 0.13). Within
the control group, the main effect of Compatibility was significant (F(1,
34)= 8.8; p= 0.007; ηp2 = 0.13), while this was not the case in the pa-
tients with NF1 (F(1, 34) = 0.5; p = 0.48; ηp2 = 0.04). While the N450
measured in control participants showed a significant distinction be-
tween compatible (−23.9 ± 3.6 μV/m2) and incompatible trials
(−31.3 ± 5.0 μV/m2), this was not the case in the group of patients
with NF1 (compatible: −34.3 ± 6.5 μV/m2; incompatible: −31.0 ±
9.1 μV/m2). Concerning theN450, no furthermain effects or interactions
were significant (all F b 2.9; all p N 0.09; all ηp2 b 0.08). Here also, the
sLORETA analysis revealed for the observed differences to originate
from the ACC (BA24).
3.2.2. Further ERPs influencing conflict detection performance
P1 and N1 ERP components for flanker and target stimuli are shown
in Fig. 2.
Regarding the amplitudes of the P1Flanker and N1Flanker (representing
the perceptual categorisation and attentional selection of the Flanker
stimuli, respectively), analyses revealed no significant main effects of
any of the factors and no significant interactions between them (all
F b 2.45; all p N 0.08; all ηp2 = 0.19).
Examining the perceptual categorisation of the target via the P1Target
component, we found a significant main effect of Compatibility
(F(1,34) = 22.4; p b 0.001; ηp2 = 0.39). Amplitudes of the P1Target
were significantly more positive in incompatible (44.5 ± 6.3 μV/m2)
compared to compatible trials (37.7±5.8 μV/m2). All othermain effects
and interactions, including those containing the factor Group, were not
significant (all F b 1.9; all p N 0.15; all ηp2 b 0.15).
Concerning the N1Target component, which indicates attentional se-
lection processes related to the target stimulus, we found a significant
main effect of Compatibility (F(1,34) = 8.0; p = 0.008; ηp2 = 0.19).
The N1Target was more negative in incompatible (−3.2 ± 5.5 μV/m2)
than in compatible (4.2 ± 4.6 μV/m2) trials. All other main effects and
interactions, including those containing the factor Group, were not sig-
nificant (all F b 2.9; all p N 0.09; all ηp2 b 0.08).
As response selection processes may also have a significant impact
on conflict processing, we additionally examined the amplitude of the
P3 (see Fig. 3). Here, we only found a trend level main effect of Group
(F(1,34)= 3.6; p= 0.06; ηp2 = 0.10), with amplitudes being slightly re-
duced in patientswith NF1 (26.2±5.5 μV/m2) compared to those in the
healthy control group (39.4 ± 4.4 μV/m2). No other main effects or in-
teractions were significant (all F b 1.1; all p N 0.31; all ηp2 b 0.03).
4. Discussion
The monogenetic disorder Neurofibromatosis Type 1 (NF1) is fre-
quently associated with cognitive deficits often resembling those char-
acteristic for attention deficit disorders. One of the barriers to
successful therapeutic intervention is the wide spectrum of described
cognitive dysfunction. Inhibitory control processes have been shown
to be altered in NF1, but no closer look has yet been taken at associatedconflict monitoring processes. Thus, in the current study, we examined
conflict monitoring abilities in patients with NF1 compared to healthy
controls using a flanker task. Patients with NF1 performed significantly
slower than healthy controls but committed significantly fewer errors
overall, especially on incompatible flanker trials. No such distinctions
between compatible and incompatible trials were present concerning
reaction times. Consequently, the reported results are not purely a re-
sult of a speed-accuracy trade-off.
Neurophysiologically, it became apparent that conflict processing
seemingly takes place via two different mechanisms in the two groups.
In the healthy control participants, the amplitude of the N2 did not vary
significantly depending on flanker-target compatibility. When consid-
ering the mean values, it becomes clear that there was a trend towards
more pronounced N2 amplitudes in incompatible trials. This lack of a
significant N2-modulation (as well as the relatively poor performance
specifically on the incompatible trials) can most likely be attributed to
developmental effects concerning executive functions and the structure
and function of the ACC in this group of young adolescents
(Chmielewski et al., 2015; Ladouceur et al., 2007; Lamm et al., 2006).
In line with this interpretation, a fully developed frontal N2 has only
been found around 17 years of age (Oades et al., 1997). Concerning
the N450 in the healthy controls, we found significantly larger
Fig. 3. Event-related potentials (ERPs) (current source density) and topographic maps
showing the P3 component during compatible and incompatible flanker trials for both
groups. The time windows represented in the scalp topographies are stated in the
methods section. Positive values are given in red, negative values are given in blue. Time
point zero denotes the occurrence of the target stimulus. Negative values are plotted
downwards.
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a clear relation between conflict processing and N450 amplitude has
previously been shown to be present in adolescents (Killikelly and
Szűcs, 2013) and young adults (Passow et al., 2014; West, 2004). Over-
all, the control group examined in the present study processes cognitive
conflict through a developing conflict recognition via the N2. This is ac-
companied by a selectively enhancedN450 activation in the case of pre-
viously perceived flanker-target conflicts. As, on average, the response
took place before the occurrence of the N450 component, this conflict-
related enhancement might be beneficial in regards to preparation for
the subsequent trial.
In contrast to healthy controls, the N2 amplitude in patients with
NF1 was significantly and selectively reduced in trials with incompati-
ble flanker-target associations. Thus, an existing flanker-target conflict
did not lead to an appropriate enhancement of N2 amplitude. Source
localisation procedures suggest that these differences are due to activa-
tion modulations in the ACC (BA24) and orbitofrontal areas (BA11). As
all earlier ERPs reflecting stimulus perception and attentional selection
were not different to those measured in the healthy control group, it
is clear that the observed N2 changes do not represent an aftereffect
of an earlier deficit. Indeed, a similar lack of an N2 enhancement in
high-conflict conditions has previously been reported in other disorders
related to dopaminergic dysfunctions like Parkinson's Disease
(Willemssen et al., 2011) and Huntington's Disease (Beste et al.,
2008). Clear links between NF1 and dopaminergic transmission have
been demonstrated on the molecular level in the rodent model
(Brown et al., 2010, 2011; Diggs-Andrews et al., 2013; Diggs-Andrews
and Gutmann, 2013; van der Voet et al., 2016) and clinically via signifi-
cant improvements of cognitive symptoms throughmethylphenidate, a
dopamine reuptake inhibitor (Lidzba et al., 2014; Mautner et al., 2002).Along these lines, the lack of an N2 enhancement in patients with NF1
observed in the current study can also be compared to that in patients
with ADHD, where conflict monitoring has also been shown to be defi-
cient (Albrecht et al., 2008). Consequently, our results add strongneuro-
physiological support to the hypothesis of a dopaminergic dysfunction
in patients with NF1 as a putative root of the deficient conflict-depen-
dent N2 enhancement. So far, it is unclear how this dopaminergic dys-
function in patients with NF1 changes as they move through
adolescence into adulthood. Cognitive problems, however, have been
shown to persist into adulthood and to continue to be highly impairing
(Mautner et al., 2015).
Furthermore, no compatibility-dependent amplitude distinctions
were found in regards to N450 in patients with NF1. However, when
considering the waveforms more closely, it becomes apparent that
N450 amplitudes in this group are always of a similarly highmagnitude
as it is the case in incompatible trials in the control group. This suggests
that in patients with NF1, the lack of a conflict-related N450-enhance-
ment may be compensated via a generally higher investment of cogni-
tive resources at this stage of information processing. Source
localisation suggests for these differences to originate in the ACC
(BA24). While healthy controls reactively shift between states of high
and low cognitive control depending on the perceived stimuli, patients
with NF1maintain a consistently higher level of engaged cognitive con-
trol resources. Interestingly, a very similar pattern concerningN450 am-
plitudes has previously been found in childrenwith learning disabilities
(Liu et al., 2014). Since the behavioural results suggest that cognitive
conflicts can in fact be resolved by patients with NF1, the adaptive reli-
ance on a continuously heightened flanker-target compatibility pro-
cessing via the N450 indeed seems to be an efficient strategy of
dealingwith conflicts. The disadvantage of this reliance on amechanism
occurring somewhat later during information processing seems to be
the generally slower reaction time in the patient group. The mecha-
nisms underlying the intact (and even compensatory) functioning of
theN450 in patients with NF1 cannot be fully explained, as the neurobi-
ological underpinnings of the N450 have not yet been clearly defined.
Overall, patients with NF1 seem to achieve successful conflict monitor-
ing performance through a consistently enhanced N450 activation,
which may aid the preparation of conflict processing in the subsequent
trial. Thismay compensate for dysfunctions in earlier conflict processing
mechanisms (N2) which are most likely caused by the dopaminergic
deficit inherent to the disorder.
In the current study, similar compensatorymechanisms could not be
found in any of the other examined ERPs, with components reflecting
early perceptual and attentional processing (flanker/target P1 and N1)
and top-down response inhibition (P3) not differing between the two
groups. Compensating for the reduced conflict-related N2 enhancement
via an increased early sensory processing would have been an ineffi-
cient compensatory strategy, as it would also have increased conflict
perception, thus resulting in even higher conflict processing demands.
Concerning the P3, we found a trend level amplitude reduction in the
patient group. This can probably also be explained by the dopaminergic
dysfunction in the patient group, as the P3 has been shown to be signif-
icantlymodulated by dopamine (Beste et al., 2010; Polich, 2007; Ratsma
et al., 2001). Consequently, response selection processes reflected by
the P3 could not be used as a compensatory mechanism in this context.
This lack of changes in other processing stages supports the specificity
of our findings concerning the two different pathways towards success-
ful conflict monitoring in healthy controls and patients with NF1.
Overall, conflict processing is indeed not per se deficient in patients
with NF1. However, the dopamine deficiency in this group likely leads
to a reduced ability to process conflicts via the N2 ERP. To compensate
for this, an alternative route via a constantly enhanced N450 is used to
achieve successful conflict processing in this group. The price for this
is a general response slowing. Clinically, precisely this slower response
speed may be the main contributor to the observed attentional prob-
lems and ADHD-like symptoms frequently reported in patients with
504 A. Bluschke et al. / NeuroImage: Clinical 14 (2017) 499–505NF1 (Kayl and Moore, 2000; Mautner et al., 2015; North et al., 1997;
Pride et al., 2012). In fact, we found a similar pattern of reduced reaction
times and somewhat altered neurophysiological processing mecha-
nisms in patients with NF1 in a GoNogo task (Bluschke et al., in press).
Here we could show that, although there are clear similarities on the
clinical level, neurophysiological processes clearly differ between pa-
tients with NF1 and those with ADHD. To assess and classify these def-
icits further, the N450 may prove to be a useful biomarker in the
future andmay thus beused as a target parameterwhen assessing treat-
ment approaches. Here, it would be particularly interesting to examine
how conflict monitoring in general and possible compensatory mecha-
nisms in particular are affected bypharmacological interventions. As the
N2 is mainly dopaminergically modulated, an amplitude normalisation
could be expected to occur as a result of the treatmentwithmethylphe-
nidate (Acosta et al., 2006; Brown et al., 2010; Mautner et al., 2002),
whereas no clear hypothesis can be derived regarding the N450. Specif-
ically, the examination of such compensatorymechanismsmay add sig-
nificant value to the understanding of the heterogeneous cognitive
deficits in juvenile and adult patients with NF1.Competing financial interests
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